Tulabing, Analyn .
HRN: 28-47-40 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/06/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
03/06/2026
03/13/2026
IV
1g
Ptor
D& C
Checking Initial Appropriateness